This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
For now, semaglutide remains the only approved and widely available option for both weight loss and diabetes
Your board-certified provider designs a personalized semaglutide protocol based on your labs and health history
Moxit Shah, Endocrinologist, Ahmedabad What is Yurpeak
Zorina A, Zorin V, Isaev A, Kudlay D, Vasileva M, Kopnin P